Alnylam Pharmaceuticals I... (ALNY)
NASDAQ: ALNY
· Real-Time Price · USD
457.12
8.21 (1.83%)
At close: Aug 18, 2025, 3:59 PM
458.00
0.19%
After-hours: Aug 18, 2025, 07:52 PM EDT
Alnylam Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -66.28M | -57.48M | -83.76M | -111.57M | -16.89M | -65.94M | -137.87M | 147.75M | -276.02M | -174.1M | -207.49M | -405.92M | -277.4M | -240.34M | -258.46M | -204.51M | -189.56M | -200.29M |
Depreciation & Amortization | 13.94M | 14.4M | -20.55M | 48.7M | 15M | 13.52M | 13.48M | 23.53M | 23.45M | 26.08M | 24.89M | 20.65M | 30.55M | 9.46M | 21.45M | 23.22M | 22.16M | 22.86M |
Stock-Based Compensation | 111.68M | 56.71M | 91.64M | 45.8M | 89.29M | 45.35M | 41.99M | 63.94M | 75.8M | 39.95M | 42.77M | 128.12M | 30.47M | 29.29M | 44.58M | 33.37M | 32.08M | 55.69M |
Other Working Capital | -6.3M | -60.09M | 46.55M | -21.7M | -140.21M | -116.86M | 29.6M | 9.98M | -17.18M | -22.91M | -44.05M | -18.78M | -31.91M | -52.85M | 15.6M | -36.87M | -23.94M | -50.52M |
Other Non-Cash Items | 34.57M | 75.45M | -7.79M | 30.05M | 86.06M | 46.4M | 98.91M | 59.41M | 24.4M | 27.74M | 21.54M | 137.21M | 60.13M | 90.36M | 51.82M | 33.05M | 30.41M | 58.96M |
Deferred Income Tax | 9.73M | 9.64M | n/a | n/a | n/a | 454K | -53.1M | 39.26M | 28.82M | n/a | n/a | n/a | n/a | n/a | 5.58M | -18.69M | 4.43M | -47.02M |
Change in Working Capital | 50.08M | -217.05M | -74.21M | 30.73M | -49.3M | -121.3M | 6.79M | 25.53M | 64.58M | -86.14M | -13.68M | 4.65M | 33.43M | -59.96M | -15.11M | -465K | -21.38M | -125.87M |
Operating Cash Flow | 153.73M | -118.31M | -94.66M | 43.71M | 124.16M | -81.52M | -29.8M | 359.41M | -58.99M | -166.47M | -131.98M | -115.28M | -122.82M | -171.19M | -150.14M | -134.04M | -121.86M | -235.66M |
Capital Expenditures | -14.29M | -8.97M | -9.09M | -4.19M | -8.02M | -12.97M | -15.31M | -17.09M | -15.92M | -13.89M | -21.64M | -16.51M | -16.05M | -17.86M | -21.89M | -26.06M | -11.25M | -17.18M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | 225.35M | -10.77M | -7.21M | -49.23M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -468.81M | -450.47M | -486.71M | -449.58M | -315.61M | -460.09M | -589.16M | -421.46M | -377.14M | -435.75M | -723.38M | -157.31M | -461.57M | -634.71M | -682.97M | -458.33M | -168.86M | -345.95M |
Sales Maturities Of Investments | 332.47M | 524.38M | 443.01M | 423.52M | 357.57M | 405.44M | 363.81M | 432.22M | 384.35M | 373.42M | 604.72M | 492.71M | 628.92M | 505.22M | 291.45M | 396.12M | 337.3M | 438.68M |
Other Investing Acitivies | 9.25M | 48.83M | -117K | n/a | n/a | n/a | -225.35M | 6.33M | 7.21M | 49.23M | 381K | -5M | -8.5M | -75K | -1K | n/a | -165K | -4.2M |
Investing Cash Flow | -141.38M | 113.77M | -52.91M | -30.25M | 33.94M | -67.62M | -240.66M | -10.76M | -8.71M | -76.22M | -139.91M | 313.89M | 142.79M | -147.42M | -413.4M | -88.27M | 157.02M | 71.35M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -777K | 136.17M | n/a | n/a | 250M | 493.75M | 243.75M | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -27.46M | -5.28M | -5.28M | -5.28M | -1.28M | 3.05M | 8.33M | 8.33M | 4M | 4M | 7.5M | 7.83M | 7.83M | 7.83M | -2.75M | 7.7M | 4.2M | 4.2M |
Financial Cash Flow | 53.76M | 44.08M | 31M | 102.75M | 131.5M | 28.91M | 39.23M | 33.14M | 53.39M | 46.37M | 63.44M | 297.02M | 30.34M | 34.96M | 292.29M | 573.84M | 329.81M | 51.18M |
Net Cash Flow | 93.61M | 53.6M | -133.85M | 131.31M | 286.61M | -130.81M | -220.34M | 375.23M | -14.44M | -194.15M | -206.83M | 497.65M | 41.48M | -285.89M | -274.31M | 348.39M | 366.06M | -117.04M |
Free Cash Flow | 139.44M | -127.28M | -103.76M | 39.52M | 116.14M | -94.49M | -45.1M | 342.32M | -74.91M | -180.37M | -153.61M | -131.79M | -138.87M | -189.05M | -172.03M | -160.1M | -133.1M | -252.84M |